Back to MDGL
J. Safra Sarasin Holding AG → MDGL
J. Safra Sarasin Holding AG MDGL Position History
Madrigal Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$962K
Q3 2026
Peak value
$1.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.1M |
| Q4 2025 | $900K |
| Q1 2026 | $1.2M |
| Q2 2026 | $1M |
| Q3 2026 | $962K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $962K | 1.9K | — | — |
| Q2 2026 | $1M | 1.9K | — | — |
| Q1 2026 | $1.2M | 2.3K | — | — |
| Q4 2025 | $900K | 1.5K | — | — |
| Q3 2025 | $1.1M | 2.4K | — | — |
Other funds holding MDGL
$728.8M
$719.5M
$319.1M
$283M
$283M
$237.6M
$212.9M
$212.9M